# Serine Supplementation for Obese Subjects With Fatty Liver Disease

> **NCT02599038** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hanns-Ulrich Marschall** · enrollment: 10 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Serine supplementation

## Key facts

- **NCT ID:** NCT02599038
- **Lead sponsor:** Hanns-Ulrich Marschall
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02599038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02599038, "Serine Supplementation for Obese Subjects With Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02599038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*